2019
DOI: 10.1016/j.stem.2019.08.013
|View full text |Cite
|
Sign up to set email alerts
|

Loss of SATB1 Induces p21-Dependent Cellular Senescence in Post-mitotic Dopaminergic Neurons

Abstract: Highlights d FACS of NURR1::GFP dopaminergic (DA) precursors enriches DA neuron culture purity d SATB1 KO DA neurons show hallmarks of cellular senescence, including SASP d SATB1 is required to repress CDKN1A in DA neurons d Senescence induced by SATB1 reduction in vivo induces microglial activation

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
122
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 104 publications
(129 citation statements)
references
References 98 publications
(117 reference statements)
5
122
1
Order By: Relevance
“…In addition, the osteogenesis process simultaneously negatively regulated via the TWIST/E2A/p21 axis. Studies have shown that p21 protein participates in many cell responses, inhibits cell proliferation, promotes cell differentiation and accelerates cell aging [30][31][32]. In addition, p21 also plays an essential role in the biological behavior of BMSCs [33][34][35].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, the osteogenesis process simultaneously negatively regulated via the TWIST/E2A/p21 axis. Studies have shown that p21 protein participates in many cell responses, inhibits cell proliferation, promotes cell differentiation and accelerates cell aging [30][31][32]. In addition, p21 also plays an essential role in the biological behavior of BMSCs [33][34][35].…”
Section: Discussionmentioning
confidence: 99%
“…Among the list of genes underlying a direct or indirect regulation through methylation changes triggered by Gadd45b overexpression, the decrease in expression did not correlate with a specific direction of methylation changes towards hypo- or hypermethylated CpGs but rather with a change in the methylation state throughout the gene body. Satb1 has been described as a dopaminergic-specific regulator of senescence 83 , a dopaminergic neuron cell survival factor 84 and a regulator of global chromatin structuration 85, 86 . The decline in Satb1 expression at 90d p.i.…”
Section: Discussionmentioning
confidence: 99%
“…After 30 minutes at RT in 100 μM glycine buffer (for TH/mCherry and TH/ORF1p) or 30 minutes at 100°C in demasking citrate buffer (10 mM, pH 6, 0.05% Tween) (for TH/MeCP2, H3K9 or γ-H2AX), sections were first blocked in 10% Fetal Bovine Serum (FBS, Gibco) in the presence of 0.5% Triton X-100 for 1 hour at RT and incubated with primary antibodies overnight at 4°C, washed and further incubated with secondary antibodies for 1 hour at RT. The following primary antibodies used: anti-γ-H2AX (mouse, 1/200, Millipore, clone JBW301), anti-TH (chicken, 1/500, Abcam, ab76442), anti-ORF1p (guinea pig, 1/200, in-house, clone 09 as in 83 , anti-mCherry (mouse, 1/200, Clontech 632543), rabbit anti-H3K9me3 (rabbit, 1/200, Abcam, ab8898) and anti-MeCP2 (rabbit, 1/200, Millipore MABE328). Sections were incubated with appropriate secondary antibodies (488 anti-chicken, 546 anti-mouse, 647 anti-guinea pig, 647 anti-rabbit, 647 anti-mouse, Alexa Fluor, Life Technologies)…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…These include nanotechnology-based approaches for detection, site-specific delivery of senolytics and/or senoprobes, and successful elimination of SCs [ 83 , 107 , 108 , 109 , 110 ]. As cellular senescence may be implicated in the pathogenesis of age-related neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease [ 111 , 112 ], the use of nano-senolytics in the central nervous system (CNS) seems promising. One should remember that nano-based systems are able to overcome the blood–brain barrier and improve the delivery of encapsulated therapeutic agents and dietary polyphenols at lower systemic doses [ 68 , 74 ].…”
Section: Senolytics and Senotherapymentioning
confidence: 99%